Friday, September 4, 2026
27.2 C
Bengaluru

Medical Rep to Doctorate in Human Resources and Board of Directors

MVS Murthy

I began my career as a Medical Rep with Lupin immediately after my graduation in my hometown Visakhapatnam. Soon, the MNC bug bit me and I had opportunity to join the erstwhile Ciba-Geigy, which eventually became today’s Novartis. After spending a good amount time at Ciba-Geigy, my desire to try something new and get out of the comfort zone drew me to an opportunity with National Dairy Development Board (IIL – An Animal Health Company) and relocated to Delhi. I was responsible for sales in the Northern Region, in addition to administrative work with DCGI & Ministry of External Affairs (for exports). I regard this as the best period of learning and exposure.

However, my desire to get back to human healthcare drew me to an opportunity with Pharmacia as a First Line Manager. Two years later, Pfizer took over Pharmacia and during the transition period I was offered the role of Field Training Manager, apart from the First Line Manager’s role. I consulted my peers and seniors and decided to give it a try. Only to realize that I was indeed passionate about Training & Development. I did not have to look back thereafter. Later, I moved to Dr. Reddy’s as Training Manager and I was instrumental in several new initiatives in Training & Development.

That was the time I seriously contemplated to make a career shift into Human Resources and the Future Group opportunity was just there for the asking. nFDIL was a group company with a mandate for captive IT/ITES services for Future Group. The development center was setup at Ahmedabad, and I am proud to say that I was instrumental in getting the infrastructure and support services in place to start the operations without delay. I had the opportunity to kickstart HR delivery engagement and started scaling newer heights. Ramping up teams and skill development apart from HR Operations kept me busy.

I dedicate my success to my managers throughout the journey and my supportive family. In pursuit of achieving career growth I kept up my passion for academics, and successfully complete post-graduation in HR from Symbiosis and doctorate in HR from Pacific University.

Apart from serving on the nFDIL board as an independent Director, I also held honorary positions as Advisory to the Board of Studies with Nirma University, Gitam University and Gujarat Technological University. I also had industry and academic interactions at XLRI Jamshedpur, IIM Ahmedabad, Ahmedabad Management Association, Society for Human Resources Management (SHRM), FICCI, ETCIO Speak, Cornerstone Events and People Matters.

 

 

 

 

 

 

 

Hot this week

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

How To See Dr Reddy’s Nestle In The Wellness Shift

GLP-1 medicines such as semaglutide and tirzepatide are changing...

Topics

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

How To See Dr Reddy’s Nestle In The Wellness Shift

GLP-1 medicines such as semaglutide and tirzepatide are changing...

How To Power The India Biopharma Regulatory Revolution Now

Beyond the Pharmacy of the World: Why India's Biopharma...

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...
spot_img

Related Articles

spot_imgspot_img